Target intelligence / Profile preview

β-Glucan immunomodulatory receptors (primarily Dectin-1, complement receptor 3, and Toll-like receptors)

Molecular classification
Receptor (C-type lectin, integrin, PRR), Other (pattern recognition receptor family)
01

Overview

The query refers to a broad biological process—modulation of immune responses via alteration of the gut microbiota and anti-inflammatory effects of phytochemicals such as β-glucan and flavonoids—not a single discrete molecular target. β-Glucans are varied polysaccharides found in cereals, yeast, fungi, and bacteria. They exert immunomodulatory and anti-inflammatory effects primarily through interaction with specific receptors on immune cells, namely Dectin-1 (a C-type lectin receptor), complement receptor 3 (CR3), and Toll-like receptors (TLR2, TLR4, TLR6)[1][3][5]. Binding of β-glucans to these pattern-recognition receptors (PRRs) triggers cellular signaling pathways that enhance phagocytosis, stimulate cytokine production, and regulate both innate and adaptive immunity[1][5][6]. The immunological effects of β-glucans are further influenced by interactions with the gut microbiota, where microbial fermentation may produce metabolites (such as butyrate and lactic acid) associated with anti-inflammatory activity and improved metabolic health[2]. However, the target listed—"Immune response modulation via gut microbiota alteration and anti-inflammatory effects of phytochemicals such as beta-glucan and flavonoids"—is too broad and functionally refers to multiple molecular targets (a set of PRRs) and physiological effects, not a single defined molecule or receptor. Important caveat: The target described is not a canonical therapeutic target (such as a defined enzyme, receptor, or transporter) but a complex physiological mechanism involving several receptor types (notably Dectin-1, CR3, and TLRs) and cellular pathways. Therefore, structured target information cannot be assigned to a single molecule; the entry is best classified as incorrect or overly broad[1][3][5].

Other names
β-Glucan receptorsDectin-1Complement receptor 3 (CR3)Toll-like receptor 2/4/6 (TLR2/4/6)Pattern recognition receptors (PRR)C-type lectin receptorGlucan receptor
02

Mechanism of action

Ligand-induced activation of innate immune receptors (e.g., Dectin-1, CR3, TLR2/4/6), leading to downstream immune cell activation and anti-inflammatory or immune-stimulating effects

03

Biological functions

Immune responseInflammation modulationPathogen recognitionCytokine productionPhagocytosis
04

Disease associations

InflammationCancerInfectionMetabolic diseases (e.g., type 2 diabetes)Cardiovascular disease
05

Safety considerations

Potential for immune overstimulation or unwanted activation in autoimmune-prone individuals (rare)Quality/purity/contamination of commercial β-glucan products
06

Interacting drugs

None (β-glucans and some flavonoids are dietary modulators/ligands, not drugs that bind a single defined molecular target)
07

Biomarkers

Cytokines (e.g., TNF-α, IL-6, IL-10)Metabolites (e.g., dihydroxyphenylacetic acid, caffeic acid, acetic acid, butyric acid, lactic acid)

Beyond the preview

Go deeper on β-Glucan immunomodulatory receptors (primarily Dectin-1, complement receptor 3, and Toll-like receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β-Glucan immunomodulatory receptors (primarily Dectin-1, complement receptor 3, and Toll-like receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call